[go: up one dir, main page]

AU2001284978A1 - Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain - Google Patents

Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain

Info

Publication number
AU2001284978A1
AU2001284978A1 AU2001284978A AU8497801A AU2001284978A1 AU 2001284978 A1 AU2001284978 A1 AU 2001284978A1 AU 2001284978 A AU2001284978 A AU 2001284978A AU 8497801 A AU8497801 A AU 8497801A AU 2001284978 A1 AU2001284978 A1 AU 2001284978A1
Authority
AU
Australia
Prior art keywords
immunoconjugate
sensitization
transfection
cancer cells
cell death
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284978A
Inventor
Raj K Puri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2001284978A1 publication Critical patent/AU2001284978A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2001284978A 2000-08-31 2001-08-15 Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain Abandoned AU2001284978A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22984200P 2000-08-31 2000-08-31
US60229842 2000-08-31
PCT/US2001/025663 WO2002017968A2 (en) 2000-08-31 2001-08-15 Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain-2

Publications (1)

Publication Number Publication Date
AU2001284978A1 true AU2001284978A1 (en) 2002-03-13

Family

ID=22862891

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284978A Abandoned AU2001284978A1 (en) 2000-08-31 2001-08-15 Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain

Country Status (2)

Country Link
AU (1) AU2001284978A1 (en)
WO (1) WO2002017968A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087758A2 (en) * 2003-03-26 2004-10-14 Neopharm, Inc. Il 13 receptor alpha 2 antibody and methods of use
GB2400662B (en) * 2003-04-15 2006-08-09 Westerngeco Seismic Holdings Active steering for marine seismic sources
US9623117B2 (en) * 2011-04-04 2017-04-18 Wisconsin Alumni Research Foundation Method for selective targeting and entry of bacterial toxins to cells
WO2014072888A1 (en) * 2012-11-07 2014-05-15 Pfizer Inc. Anti-il-13 receptor alpha 2 antibodies and antibody-drug conjugates
CN108456250B (en) * 2017-02-17 2025-11-28 恺兴生命科技(上海)有限公司 Antibodies targeting IL-13RA2 and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614191A (en) * 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
US20020197266A1 (en) * 2000-02-08 2002-12-26 Waldemar Debinski Immunotherapy using interleukin 13 receptor subunit alpha 2

Also Published As

Publication number Publication date
WO2002017968A3 (en) 2002-04-18
WO2002017968A2 (en) 2002-03-07
WO2002017968A9 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
AU2003227477A1 (en) Sensitizing dye solar cell
AU2002228840A1 (en) Preparation of fuel cell electrode assemblies
AU2003294539A1 (en) Tubular direct methanol fuel cell
AU1121102A (en) Solar cells incorporating light harvesting arrays
AU4972900A (en) Use of anti-vegf antibody to enhance radiation in cancer therapy
EP1791980A4 (en) Reverse transfection of cell arrays for structural and functional analyses of proteins
IL164079A0 (en) Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
AU2003243212A1 (en) Improved fuel cell
EP1644135A4 (en) IMPROVED SOLAR CELLS
EP1781328A4 (en) Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby
IL156673A0 (en) Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
AU2002214576A1 (en) Genes related to development of refractory prostate cancer
AU2001284978A1 (en) Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain
AU2002235168A1 (en) Targeting pluripotent stem cells to tissues
IL162343A0 (en) Cell constructs cultured in vitro, preparation anduses
NO20000667D0 (en) Fuel cell with direct conversion of methanol to electricity
AU2003286645A1 (en) Antibody-mediated induction of tumor cell death
GB0414693D0 (en) Improvements relating to fuel cells
AU2001272103A1 (en) Stable cell lines resistant to apoptosis and nutrient stress and methods of making same
AU2003277633A1 (en) Insulin-expressing human islet cell lines capable of reversibly proliferating and use thereof
AU4459100A (en) Cell cycle genes and methods of use
AU4297300A (en) Use of coxsackie viruses for improving cell transfection
AU2003253638A1 (en) Fish produced by nuclear transfer from cultured cells
TW476333U (en) Configuration structure of electromotive motorbike using fuel cell as energy system
GB0227960D0 (en) Improvement to direct fuel cell